2C-C
Sign in to saveAlso known as 4-chloro-2,5-dimethoxyphenethylamine, 2,5-dimethoxy-4-chlorophenethylamine, 2-(4-chloro-2,5-dimethoxyphenyl)ethan-1-amine
2C-C, also known as 4-chloro-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally.
Key facts
- Drug.Verifiedfields
- verified
- Drug.Watchedfields
- verified
- Drug.verifiedrevid
- 477216097
- Drug.image
- 2C-C.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 200px
- Drug.image2
- 2C-C-3d-sticks.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 175px
- Drug.routes_of_administration
- Oral
- Drug.class
- Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen
- Drug.ATC_prefix
- None
- Drug.legal_BR
- F2
- Drug.legal_CA
- Schedule III
- Drug.legal_DE
- Anlage I
- Drug.legal_US
- Schedule I
- Drug.onset
- 1.5–2 hours
- Drug.duration_of_action
- 4–8 hours
via Wikipedia infobox
~6 min read
Encyclopedic overview
19 sectionsContents
- Use and effects
- Interactions
- Pharmacology
- Pharmacodynamics
- Chemistry
- Synthesis
- Analogues
- History
- Society and culture
- Legal status
- Canada
- China
- Finland
- Germany
- Sweden
- United States
- See also
- References
- External links
2C-C, also known as 4-chloro-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally.
2C-C was first described in the scientific literature by Alice Cheng and Neal Castagnoli in 1984. It was described in greater detail by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved). The drug is Schedule I of section 202(c) of the Controlled Substances Act in the United States, signed into law as of July 2012 under the Food and Drug Administration Safety and Innovation Act.
Excerpted from Wikipedia’s “2C-C” article, available under the CC BY-SA 4.0 licence.